Novel 2-Thioxanthine and Dipyrimidopyridine Derivatives: Synthesis and Antimicrobial Activity.

Several fused imidazolopyrimidines were synthesized starting from 6-amino-1-methyl-2-thiouracil (1) followed by nitrosation, reduction and condensation with different aromatic aldehydes to give Schiff's base. The dehydrocyclization of Schiff's bases using iodine/DMF gave Compounds 5a-g. The methylation of 5a-g using a simple alkylating agent as dimethyl sulfate ((CH₃)₂SO₄) gave either monoalkylated imidazolopyrimidine 6a-g at room temperature or dialkylated derivatives 7a-g on heating 6a-g with ((CH₃)₂SO₄). On the other hand, treatment of 1 with different aromatic aldehydes in absolute ethanol in the presence of conc. hydrochloric acid at room temperature and/or reflux with acetic acid afforded bis-5,5́-diuracylmethylene 8a-e, which cyclized on heating with a mixture of acetic acid/HCl (1:1) to give 9a-e. Compounds 9a-e can be obtained directly by refluxing of Compound 1 with a mixture of acetic acid/HCl. The synthesized new compounds were screened for antimicrobial activity, and the MIC was measured.

1. Introduction

The importance of fused uracils, a common source for the development of new potential therapeutic agents [1,2], is well known. Fused n class="Chemical">uracils continue to attract considerable attention because of their great practical usefulness, primarily due to a very wide spectrum of biological activities. Uracils and their derivatives are considered to be important for drugs. A large number of uracil derivatives are reported to exhibit antimycobacterial [3], antitumor [4], antiviral [5] and anticancer [6,7] activities. In recent years, considerable attention has been focused on the development of new methodologies to synthesize many kinds of xanthine rings. Indeed, purines represent an important class of heterocyclic compounds having wide range of pharmaceutical and biological activities. The replacement of the oxygen by a sulfur atom may induce changes in the properties of the nucleobases and the ability to stabilize the DNA [8,9]. Furthermore, it has been suggested that the presence of the thio-group may enhance the probability of mutations that occur in DNA [10]. Therefore, versatile and widely-applicable methods for the synthesis of thiopurines are of considerable interest. On the other hand, acridine derivatives are known as antibacterial [11] and antitumor drugs [12,13] with clinical importance. The mechanism of the antibacterial action of acridine derivatives seems to be connected to the intercalation to DNA [14]. 1-Aza analogues of aminacrine and rivanol were, however, shown to be more active than the parent compounds against a hemolytic streptococcal strain [15], analogues of aminacrine and rivanol derived from 1:10-diazaanthracenes [16,17,18].

Our strategy has been directed towards the synthesis of a series of new n class="Chemical">thiouracil fused ring analogs, and their biological effects are determined.

2. Results and Discussion

2.1. Chemistry

2-Thioxanthine [19] and n class="Chemical">3-methyl-2-thioxanthine were previously prepared by different methods [20,21]. The alkylation of N-H or S-H takes place by many different reported methods in the literature [22,23]. Herein, we use one of the simplest methylating agents and a simple method. 8-Aryl-3-methyl-2-thioxanthines (5a–g) [21] were synthesized by the treatment of 6-amino-1-methyl-2-thiouracil (1) with sodium nitrite in acetic acid, affording 5-nitrosouracil 2, followed by the reduction using ammonium sulfide, giving 4,5-diminouracil 3. The obtained Compound 3 was condensed with different aromatic aldehydes in ethanol, affording 5-arylideneaminouracil 4a–g, which undergoes dehydrocyclization via the reaction with I2/DMF, giving 5a–g in a good yield. Methylation of 5a–g takes place by the reaction with dimethyl sulfate in 0.5 N NaOH and ethanol for 1 h at room temperature with stirring to produce the target mono-alkylated thioxanthines 6a–g; the methylation takes place smoothly on S-H (C-2). While refluxing of 6a–g with dimethyl sulfate in 0.5 N NaOH and ethanol for 1 h gave 7a–g, the methylation was carried out on N-H (C-9), as well as on the -OH group of the phenyl-8 in 7f,g as shown in Scheme 1. The structures of the synthesized compounds were proven by 1H-NMR, elemental analysis, mass and IR spectra. 1H-NMR (DMSO-d6) for Compounds 6a–g showed a characteristic signals at 4.0–4.54 ppm for S-CH3 and a characteristic signal at 10.02–11.11 ppm for N-H (9), while Compounds 7a–f showed the disappearance of N-H (9) signals and the appearance of new N-CH3 at 3.38–3.79 ppm. Mass spectra of Compound 6b showed fragmentation at M+ + 2 = 308, M+ = 306, and Compound 7b showed M+ + 2 = 322, M+ = 320, due to the presence of the Cl atom attached to the phenyl group, as well as in compound 6d showed fragmentation at M+ + 2 = 353, M+ = 351, and 7d M+ + 2 = 367, M+ = 365, due to the presence of the Br atom; also, Ms of compounds 7f showed M+ = 316, which explain the methylation of para OH of the phenyl group 8.

Scheme 1

Synthesis of 8-aryl-3,9-dimethyl-2-methylthio-3,9-dihydro-6H-purin-6-one.

i = NaNO2/AcOH/r.t.; ii = (NH4)2S; iii = ArCHO/EtOH; iv = I2/DMF; v = (CH3)2SO4/NaOH/EtOH/r.t; vi = (CH3)2SO4/NaOH/EtOH/reflux; where R in 6a–g are: a = H; b = 4-Cl; c = 2-OCH3; d = 4-Br; e = 4-F; f = 4-OH; g = 2-OH; R in 7a–g are: a = H; b = 4-Cl; c = 2-OCH3; d = 4-Br; e = 4-F; f = 4-OCH3; g = 2-OCH3.

As part of our synthetic studies of fused n class="Chemical">uracils, we have reported the synthesis of dipyrimidopyridines [24,25]. Refluxing of Compound 1 with different aromatic aldehydes in acetic acid and/or absolute ethanol in the presence of conc. hydrochloric acid with stirring at room temperature produced the bis derivatives 8a–e, which on refluxing compound 8a for 1 h with a mixture of AcOH/HCl afforded the dipyrimidopyridine derivatives 9a. Compounds 9a–e can be synthesized directly in one step by refluxing Compound 1 with a mixture of AcOH/HCl for 4–6 h, as shown in Scheme 2. 1H-NMR (DMSO-d6) of Compounds 8a–e showed a characteristic signal at 5.46–5.62 ppm for CH-5 and at 7.58–7.92 for NH2 (6), while 1H-NMR for Compounds 9a–e showed a characteristic signals at 7.88–8.46 for NH-10 and at 6.06–6.22 for CH-5.

Scheme 2

Reactions of aromatic aldehydes with 6-amino-1-methyl-2-thiouracil.

Ar: a = 4-Cl-C6H4; b = 3-NO2-C6H4; c = 4-NO2-C6H4; d = 4-Br-C6H4; e = 2-HO-C6H4.

2.2. Antimicrobial Screening

Results in Table 1 reveal that there is a vast variation between tested microorganisms, whereas n class="Species">Escherichia coli as a negative bacterial strains tolerate the applicable organic compounds. On the other hand, S. aureus is a positive bacterial strain affected by the application of Compounds 7d, 8c and 9a. The most obvious inhibition zone was developed with Compound 7d with the MIC reaching 0.4 µg followed by Compounds 9a (MIC = 0.3 µg) and 8d (the lowest effect). It is worth mentioning that the inhibitory effect induced by Compound 7d was three-fold more than Compound 8d. With respect to C. albicans, it is affected by Compounds 7b, 7d, 8c and 9a with the inhibition zone ranging between 8.3 and 16.0 mm. The highest inhibition was developed after application of Compound 9a (16 mm) with the MIC reaching to 0.5 µg/mL.

Table 1

Detection of the antimicrobial activity of some organic compounds by measuring the formed inhibition zone (inhibition zone measured in mm and MIC in µg/mL).

Compd. No.	Staphylococcus aureus	Escherichia coli	Candida albicans
6a	0	0	0
6b	0	0	0
6c	0	0	0
6d	0	0	0
6e	0	0	0
6f	0	0	0
6g	0	0	0
7a	0	0	0
7b	0	0	8.3 ± 0.881
7c	0	0	0
7d	15.3 ± 0.88 * (0.4)	0	12.6 ± 1.1547 * (0.3)
7e	0	0	0
7f	0	0	0
8a	0	0	0
8b	0	0	0
8c	5.0 ±0.9 *	0	12.3 ± 0.91 * (0.3)
8d	0	0	0
8e	0	0	0
9a	14.6 ± 1.2 * (0.5)	0	16.0 ± 1.1547 * (0.5)
9b	0	0	0
9c	0	0	0
9d	0	0	0
9e	0	0	0
DMSO	0	0	0

* ±SE: standard error for three measurements; MIC: the value indicated between the brackets.

3. Experimental Section

3.1. General

Melting points were determined with an Electro Thermal Mel-Temp II apparatus and n class="Chemical">are uncorrected. All reactions were monitored by thin layer chromatography (TLC) on pre-coated silica gel plates (0.25 mm, 20 × 20 cm, 60F254, E. Merck KGaA, Konstanz, Germany) with an appropriate solvent system ((A) 1:9 CH3OH–CHCl3; (B) 1:1 tolune–ethylacetate). IR spectra were obtained in the solid state in the form of KBr discs using a Perkin-Elmer Model 1430 spectrometer (Perkin-Elmer, Akron, OH, USA) and carried out in Taif University, Taif, KSA. 1H-NMR spectra were run at 400 MHz and 13C spectra were run at 125 MHz in dimethylsulfoxide (DMSO-d6) and TMS as an internal standard. Mass spectra were recorded on GC Ms-QP 5050A mass spectrometer (Shimadzu Corporation, Tokyo, Japan) at 70 eV and microanalytical data were performed on Elementar Vario EI III CHN analyzer (Elementar, Langenselbold, Germany) at the microanalytical unit, in Regional center for Mycology and Biotechnology, Al-Azhar University, Nasr City, Egypt.

3.2. Synthesis of 8-Aryl-3-methyl-2-methylthio-3,9-dihydro-3,6H-purin-6-one (

Dimethyl sulfate (7.0 mL) was added to a mixture of NaOH (12.5 mL, 0.5 N) and 2-thioxanthines 5a–g (5 mmol). Ethanol was added gradually till completely dissolving of 2-thioxanthines. The mixture was stirred for 1 h at room temperature; the formed precipitate was collected by filtration, dried in the oven and crystallized from DMF/ethanol.

3-Methyl-2-(methylthio)-8-phenyl-3,9-dihydro-6H-purin-6-one (6a). Yield: 70%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3425 (NH), 3055 (CH aromatic), 2921 (CH aliphatic), 1688 (C=O), 1617 (C=N), 1290 (NH); 1H-NMR (DMSO-d6): 11.11 (s, 1H, NH), 7.83–7.77 (m, 2H, arom.), 7.58–7.55 (m, 3H, arom.), 4.03 (s, 3H, SCH3), 3.83 (s, 3H, NCH3); 13C-NMR (DMSO-d6): δ = 16.4 (SCH3), 29.28 (NCH3), 108.24, 114.40, 122.78, 128.01, 136.68, 142.92 (C-S), 150.76, 154.15, 154.17 (C=O) ppm; MS: m/z (%) = M+, 272 (7), 256 (9), 213 (16), 82 (100); Anal. calcd. for C13H12N4OS (272.32): C, 57.34; H, 4.44; N, 20.57. Found: C, 57.49; H, 4.51; N, 20.72.

8-(4-Chlorophenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6b). Yield: 78%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3473 (NH), 3013 (CH arom.), 2955 (CH aliph.),1687 (C=O), 1612 (C=N), 1265 (NH); 1H-NMR (DMSO-d6): 10.31 (s, 1H, NH), 7.84–7.61 (d, 2H, J = 8.7, arom.), 7.60–7.58 (d, 2H, J = 8.4, arom.), 4.54 (s, 3H, SCH3), 3.63 (s, 3H, NCH3); 13C-NMR (DMSO-d6): δ = 16.6 (SCH3), 29.26 (NCH3), 107.21, 113.41, 122.78, 128.01, 136.68, 141.90 (C-S), 149.88, 153.18, 153.89 (C=O) ppm; MS: m/z (%) = M+ +2, 308 (19), M+ + 1, 307 (15), M+, 306 (54), 171 (33), 111 (28), 68 (100). Anal. calcd. for C13H11ClN4OS (306.77): C, 50.90; H, 3.91; N, 18.26. Found: C, 51.08; H, 3.94; N, 18.47.

8-(2-Methoxyphenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6c). Yield: 67%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3450 (NH), 3076 (CH arom.), 2928 and 2838 (CH aliph.), 1694 (C=O), 1629 (C=N), 1286 (NH); 1H-NMR (DMSO-d6): 10.76 (s, 1H, NH), 8.04–8.01 (d, 1H, J = 1.8, arom.), 7.50–7.50 (m, 1H, J = 1.2, arom.), 7.22–7.19 (d, 1H, J = 8.4, arom.), 7.12–7.07 (m, 1H, J = 7.5, arom.), 4.43(s, 3H, SCH3), 3.93 (s, 3H, OCH3), 3.84 (s, 3H, NCH3). MS: m/z (%) = M+, 302 (95), 257 (51), 134 (65), 68 (100). Anal. calcd. for C14H14N4O2S (302.35): C, 55.61; H, 4.67; N, 18.53. Found: C, 55.74; H, 4.74; N, 18.69.

8-(4-Bromophenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6d). Yield: 78%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3446 (NH), 3080 (CH arom.), 2924 and 2853 (CH aliph.), 1697 (C=O), 1633 (C=N), 1208 (NH); 1H-NMR (DMSO-d6): 10.88 (s, 1H, NH), 7.89–7.87 (d, 2H, J = 8.4, arom.), 7.59–7.56 (d, 2H, J = 8.1, arom.), 4.43 (s, 3H, SCH3), 3.82 (s, 3H, NCH3).MS: m/z (%) = M+ + 2, 353 (6), M+, 351 (9), 336 (12), 68 (100); Anal. calcd. for C13H11BrN4OS (351.22): C, 44.46; H, 3.16; N, 15.95. Found: C, 44.62; H, 3.12; N, 16.14.

8-(4-Fluorophenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6e). Yield: 64%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3526 (NH), 3082 (CH arom.), 2933 and 2827 (CH aliph.), 1684 (C=O), 1625 (C=N), 1216 (NH); 1H-NMR (DMSO-d6): 11.02 (s, 1H, NH), 7.69–7.54 (m, 2H, arom.), 7.30–7.25 (m, 2H, arom.), 4.14 (s, 3H, SCH3), 3.72 (s, 3H, NCH3); 13C-NMR (DMSO-d6): δ = 16.3 (SCH3), 29.23 (NCH3), 107.11, 113.42, 122.64, 127.89, 136.57, 141.48 (C-S), 149.83, 153.01, 154.23 (C=O) ppm; MS: m/z (%) = M+ + 1, 291 (16), M+, 290 (27), 122 (32), 68 (100); Anal. calcd. for C13H11FN4OS (290.31): C, 53.78; H, 3.82; N, 19.30. Found: C, 53.87; H, 3.89; N, 19.37.

8-(4-Hydroxyphenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6f). Yield: 63%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3615 (OH), 3406 (NH), 3071 (CH arom.), 2938 and 2839 (CH aliph.), 1700 (C=O), 1602 (C=N), 1253 (NH); 1H-NMR (DMSO-d6): 13.23 (s, 1H, OH), 10.02 (s, 1H, NH), 7.66–6.64 (d, 2H, J = 4.2, arom.), 6.88–6.86 (d , 2H, J = 6.9, arom.), 4.21 (s, 3H, SCH3), 3.83 (s, 3H, NCH3). MS: m/z (%) = M+, 288 (34), 258 (7), 120 (23), 82 (100), 67 (60); Anal. calcd. for C13H12N4O2S (288.32): C, 54.15; H, 4.20; N, 19.43. Found: C, 54.29; H, 4.27; N, 19.66.

8-(2-Hydroxyphenyl)-3-methyl-2-(methylthio)-3,9-dihydro-6H-purin-6-one (6g). Yield: 58%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3632 (OH), 3400 (NH), 3062 (CH arom.), 2925 and 2829 (CH aliph.), 1688 (C=O), 1624 (C=N), 1251 (NH); 1H-NMR (DMSO-d6): 13.12 (s, 1H, OH), 10.98 (s, 1H, NH), 7.820–7.815 (d, 1H, J = 1.5, arom.), 7.15–7.01 (m, 2H, arom.), 6.87–6.80 (m, 1H, arom.), 4.29 (s, 3H, SCH3), 3.79 (s, 3H, NCH3); 16.21 (SCH3), 28.98 (NCH3), 107.10, 113.41, 122.55, 127.72, 128.17, 136.61, 141.32 (C-S), 149.83, 152.24, 154.13 (C=O) ppm; MS: m/z (%) = M+, 288 (100), 274 (33), 215 (74), 120 (69); Anal. calcd. for C13H12N4O2S (288.32): C, 54.15; H, 4.20; N, 19.43. Found: C, 54.21; H, 4.24; N, 19.62.

3.3. 8-Aryl-3,9-dimethyl-2-methylthio-3,9-dihydro-6H-purin-6-one (

Dimethyl sulfate (7.0 mL) was added to a mixture of NaOH (12.5 mL, 0.5 N) and 2-thioxanthines 6a–g (5 mmol), and ethanol was added gradually till 2-thioxanthines were completely dissolved. The mixture was heated under reflux for 1 h with stirring. The reaction mixture was evaporated under reduced pressure, and the residue was collected by filtration and crystallized from ethanol to afford Compounds 7a–g.

3,9-Dimethyl-2-(methylsulfanyl)-8-phenyl-3,9-dihydro-6H-purin-6-one (7a). Yield: 78%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3059 (CH arom.), 2980 (CH aliph.),1687 (C=O), 1609 (C=N); 1H-NMR (DMSO-d6): 7.79–7.76 (m, 2H, arom.), 7.54–7.51 (m, 3H, arom.), 4.00 (s, 3H, SCH3), 3.83 (s, 3H, NCH3), 3.72 (s, 3H, NCH3); 16.18 (SCH3), 29.38 (NCH3), 44.18 (NCH3), 108.13, 113.27, 122.42, 127.89, 136.57, 141.48 (C-S), 149.83, 153.01, 154.21 (C=O) ppm; MS: m/z (%) = M+, 286 (67), 82 (100); Anal. calcd. for C14H14N4OS (286.35): C, 58.72; H, 4.93; N, 19.57. Found: C, 58.89; H, 4.98; N, 19.64.

3,9-Dimethyl-2-(methylsulfanyl)-8-(4-chlorophenyl)-3,9-dihydro-6H-purin-6-one (7b). Yield: 82%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3068 (CH arom.), 2970 (CH aliph.), 1676 (C=O), 1623 (C=N); 1H-NMR (DMSO-d6): 7.62–7.60 (d, 2H, arom.), 7.55–7.52 (d, 2H, arom.), 4.03 (s, 3H, SCH3), 3.80 (s, 3H, NCH3), 3.66 (s, 3H, NCH3); MS: m/z (%) = M+ + 2, 322 (13), M+, 320 (30), 307 (16), 86 (11), 68 (100); Anal. calcd. for C14H13ClN4OS (320.79): C, 52.42; H, 4.08; N, 17.46. Found: C, 52.49; H, 4.13; N, 17.59.

3,9-Dimethyl-2-(methylsulfanyl)-8-(2-methoxyphenyl)-3,9-dihydro-6H-purin-6-one (7c). Yield: 71%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3092 (CH arom.), 2838 (CH aliph.), 1699 (C=O), 1633 (C=N); 1H-NMR (DMSO-d6): 7.46–7.45 (m, 1H, arom.), 7.26–7.23 (m, 2H, arom.), 7.13–7.09 (m, 1H, arom.), 4.13 (s, 3H, SCH3), 3.93 (s, 3H, OCH3), 3.79 (s, 3H, NCH3), 3.70 (s, 3H, NCH3); 16.31 (SCH3), 29.27 (NCH3), 44.16 (NCH3), 52.01 (OCH3), 108.13, 111.29, 113.27, 122.42, 127.89, 128.13, 136.57, 141.48 (C-S), 149.83, 153.01, 154.21 (C=O) ppm; MS: m/z (%) = M+, 316 (21), 302 (100), 287 (13), 243 (12), 119 (8), 70 (11), 64 (12); Anal. calcd. for C15H16N4O2S (316.37): C, 56.94; H, 5.10; N, 17.71. Found: C, 57.21; H, 5.17; N, 17.83.

3,9-Dimethyl-2-(methylsulfanyl)-8-(4-bromophenyl)-3,9-dihydro-6H-purin-6-one (7d). Yield: 79%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3079 (CH arom.), 2953(CH aliph.), 2841 (CH aliph.), 1689 (C=O), 1617 (C=N); 1H-NMR (DMSO-d6): 8.06–8.02 (m, 2H, arom.), 7.69–7.67 (m, 2H, arom.), 4.41 (s, 3H, SCH3), 3.74 (s, 3H, NCH3), 3.39 (s, 3H, NCH3); MS: m/z (%) = M+ + 2, 367 (8), M+, 365 (12), 348 (22), 68 (100); Anal. calcd. for C14H13BrN4OS (365.24): C, 46.04; H, 3.59; N, 15.34. Found: C, 46.19; H, 3.66; N, 15.46.

3,9-Dimethyl-2-(methylsulfanyl)-8-(4-fluorophenyl)-3,9-dihydro-6H-purin-6-one (7e). Yield: 69%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3074 (CH arom.), 2921 (CH aliph.), 2827 (CH aliph.), 1693 (C=O), 1618 (C=N), 1257 (NH); 1H-NMR (DMSO-d6): 7.87–7.84 (m, 2H, arom.), 7.40–7.36 (m, 2H, arom.), 4.03 (s, 3H, SCH3), 3.78 (s, 3H, NCH3), 3.67 (s, 3H, NCH3); MS: m/z (%) = M+ + 1, 305 (6), M+, 304 (18), 171 (33), 122 (54), 68 (100); Anal. calcd. for C14H13FN4OS (304.34): C, 55.25; H, 4.31; N, 18.41. Found: C, 55.34; H, 4.34; N, 18.56.

3,9-Dimethyl-8-(4-methoxyphenyl)-2-(methylsulfanyl)-3,9-dihydro-6H-purin-6-one (7f). Yield: 72%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3654 (OH), 3076 (CH arom.), 2928 (CH aliph.), 2839 (CH aliph.), 1695 (C=O), 1619 (C=N); 1H-NMR (DMSO-d6): 7.97–7.94 (d, 2H, arom.), 6.93–6.91 (d , 2H, arom.), 4.30 (s, 3H, SCH3), 4.05 (s, 3H, OCH3), 3.77 (s, 3H, NCH3), 3.64 (s, 3H, NCH3); MS: m/z (%) = M+, 316 (18), 302 (56), 268 (100), 214 (24); Anal. calcd. for C15H16N4O2S (316.37): C, 56.94; H, 5.10; N, 17.71. Found: C, 57.21; H, 5.07; N, 17.62.

3,9-Dimethyl-8-(2-methoxyphenyl)-2-(methylsulfanyl)-3,9-dihydro-6H-purin-6-one (7g). Yield: 67%; m.p. >300 °C; IR (KBr) νmax (cm−1): 3052 (CH arom.), 2830 (CH aliph.), 1674 (C=O), 1627 (C=N); 1H-NMR (DMSO-d6): 7.43–7.41 (m, 1H, arom.), 7.24–7.21 (m, 2H, arom.), 7.18–7.12 (m, 1H, arom.), 4.22 (s, 3H, SCH3), 3.81 (s, 3H, OCH3), 3.68 (s, 3H, NCH3), 3.69 (s, 3H, NCH3); MS: m/z (%) = M+, 316 (21), 302 (100), 287 (13); Anal. calcd. for C15H16N4O2S (316.37): C, 56.94; H, 5.10; N, 17.71. Found: C, 57.18; H, 5.13; N, 17.85.

3.4. Synthesis of 5,5′-Arylmethylenebis-(6-Amino-1-methyl-2-thiouracil) (

A mixture of 6-amino-1-methyl-2-thiouracil (1) (0.5 g, 2.4 mmol) and appropriate aromatic aldehydes (2.4 mmol) in absolute ethanol (20 mL) in the presence of conc. Hydrochloric acid (1mL) was stirred at room temperature for 1.5 h and/or reflux with glacial acetic acid (5 mL) for 1 h. The formed precipitate was filtered, washed with ethanol and crystallized from DMF/ethanol (3:1) into colorless crystals.

5,5'-[(4-Chlorophenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (8a). Yield: 95%; m.p. = 240–242 °C; IR (KBr) νmax (cm−1): 3442, 3340 (NH2 and NH), 3064 (CH arom.), 2871 (CH aliph.), 1732, 1662 (C=O), 1598 (C=C), 1086, 1119 (C=S), 747 (C-Cl); 1H-NMR (DMSO-d6): 12.28 (s, 2H, 2NH), 7.59 (bs, 4H, 2NH2), 7.26–7.24 (d, J = 5.9, 2H, arom.), 7.15–7.13 (d, J = 9.2, 2H, arom.), 5.48 (s, 1H, CH-5), 3.77 (s, 6H, 2 CH3); 13C-NMR (DMSO-d6): δ = 28.4 (CH), 38.7 (CH3), 91.2, 111.9, 117.2, 126.1, 129.3, 131.3, 162.2 (C=O), 171.1 (C=S) ppm; MS: m/z (%) = M+ + 2, 439 (8), M+ + 1, 438 (15), M+, 437 (22), 156 (82), 124 (77), 88 (100); Anal. calcd. for C17H17ClN6O2S2 (436.93): C, 46.73; H, 3.92; N, 19.23. Found: C, 46.98; H, 3.98; N, 19.42

5,5'-[(3-Nitrophenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (8b). Yield: 88%; m.p. = 258–260 °C; IR (KBr) νmax (cm−1): 3406, 3335 (NH2 and NH), 3057 (CH arom.), 2833 (CH aliph.), 1731, 1690 (C=O), 1528 (C=N), 1128, 1081 (C=S); 1H-NMR (DMSO-d6): 12.34 (s, 2H, 2NH), 8.03–8.01 (d, 1H, arom.), 7.9 (d, 1H, arom.), 7.63–7.61 (bs, 4H, 2 NH2), 7.54–7.50 (m, 2H, arom.), 5.60 (s, 1H, CH-5), 3.79 (s, 6H, 2 CH3); MS: m/z (%) = M+, 447 (37), 358 (48), 325 (18), 286 (100); Anal. calcd. for C17H17N7O4S2 (447.49): C, 45.63; H, 3.83; N, 21.91. Found: C, 45.85; H, 3.88; N, 22.14.

5,5'-[(4-Nitrophenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (8c). Yield: 90%; m.p. = 261–263 °C; IR (KBr) νmax (cm−1): 3450, 3328 (NH2 and NH), 3051 (CH arom.), 2992 (CH aliph.), 1714, 1663 (C=O), 1563 (C=N), 1116, 1086 (C=S); 1H-NMR (DMSO-d6): 12.34 (s, 2H, 2NH), 8.09–8.06 (d, J = 5.8, 2H, arom), 7.61 (bs, 4H, 2 NH2), 7.43–7.41 (d, J = 8.8, 2H, arom.), 5.59 (s, 1H, CH-5), 3.78 (s, 6H, 2 CH3); 13C-NMR (DMSO-d6): δ = 28.6 (CH), 39.2 (CH3), 91.7, 112.1, 117.5, 126.7, 129.6, 131.4, 162.4 (C=O), 171.3 (C=S) ppm; MS: m/z (%) = M+ , 447 (3), 377 (26), 286 (16), 198 (14), 149 (57), 125 (100); Anal. calcd. for C17H17N7O4S2 (447.49): C, 45.63; H, 3.83; N, 21.91. Found: C, 45.91; H, 3.81; N, 22.12.

5,5'-[(4-Bromophenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one) (8d). Yield: 93%; m.p. = 224–226 °C; IR (KBr) νmax (cm−1): 3442, 3308 (NH2 and NH), 3060 (CH arom.), 2946 (CH aliph.), 1727 (C=O), 1569 (C=N), 1142, 1077 (C=S); 1H-NMR (DMSO-d6): 12.28 (s, 2H, 2NH), 7.58 (bs, 4H, 2NH2), 7.39–7.37 (d, J = 5.8, 2H, arom.), 7.09–7.07 (d, J = 9.1, 2H, arom.), 5.46 (s, 1H, CH-5), 3.77 (s, 6H, 2 CH3); 13C-NMR (DMSO-d6): δ = 28.3 (CH), 38.7 (CH3), 91.4, 111.8, 117.3, 126.0, 129.2, 131.2, 162.4 (C=O), 171.3 (C=S) ppm; MS: m/z (%) = M+ + 2, 483 (5), M+, 481 (14), 449 (84), 249 (60), 208 (100), 193 (97), 167 (60); Anal. calcd. for C17H17BrN6O2S2 (481.38): C, 42.42; H, 3.56; N, 17.46 Found: C, 42.53; H, 3.58; N, 17.63.

5,5'-[(2-Hydroxyphenyl)methylene]bis(6-amino-1-methyl-2-thioxo-2,3-dihydro-pyrimidin-4(1H)-one) (8e). Yield: 89%; m.p. = 248–250 °C; IR (KBr) νmax (cm−1): 3628 (OH), 3443, 3315 (NH2 and NH), 3028 (CH arom.), 2946 (CH aliph.), 1632 and 1602 (C=O), 1482 (C=N), 1145, 1087 (C=S); 1H-NMR (DMSO-d6): 13.82 (s, 1H, OH), 12.54 (s, 2H, 2NH), 7.29 (bs, 4H, 2NH2), 7.24–7.21 (d, J = 6.0, 1H, arom.), 7.18–7.16 (d, J = 6.0, 1H, arom.), 7.13–7.11 (m, 2H, arom.), 5.62 (s, 1H, CH-5), 3.80 (s, 6H, 2 CH3); 13C-NMR (DMSO-d6): δ = 28.3 (CH), 39.1 (CH3), 91.2, 112.3, 117.6, 126.3, 128.3, 129.7, 131.3, 132.0, 162.2 (C=O), 171.1 (C=S) ppm; MS: m/z (%) = M+, 418 (1), 377 (5), 97 (12), 91 (100); Anal. calcd. for C17H18N6O3S2 (418.49): C, 48.79; H, 4.34; N, 20.08. Found: C, 48.88; H, 4.42; N, 20.32.

3.5. Synthesis of 5-Aryl-1,9-dimethyl-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido[5',4':5,6]pyrido [2,3-d]pyrimidine-4,6(1H,7H)-diones (

Two methods were used to synthesize the target Compounds 9a–e:

A mixture of acetic acid/HCl (1:1, 2mL) was added to 6-amino-1-methyl-2-thiouracil (1) (0.26 g, 1.2 mmol) and appropriate aromatic aldehydes (1.2 mmol). The mixture was heated under reflux for 4–6 h. After cooling, the formed precipitate was filtered, washed with ethanol and crystallized from DMF, affording 9a–e.

A mixture of 5,5′-arylmethylene bis(6-amino-1-methyl-2-thiouracil) (8a) (0.1 g, 0.22 mmol) and acetic acid/HCl (1:1, 2 mL) was heated under reflux for 1 h. After cooling, the formed precipitate was filtered, washed with ethanol and crystallized from DMF to afford 9a.

5-(4-Chlorophenyl)-1,9-dimethyl-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d]pyrimidine-4,6(1H,7H)-dione (9a). Yield (method A): 84%, (method B): 67%; m.p. = 298–300 °C; reflux 4 h; IR (KBr) νmax (cm−1): 3219 (NH), 3046 (CH arom.), 2818 (CH aliph.), 1704 (C=O), 1561 (C=N), 1103, 1052 (C=S); 1H-NMR (DMSO-d6): 12.58 (s, 1H, NH), 12.50 (s, 1H, NH), 8.32 (s, 1H, NH (10)), 8.15–8.13 (d, J = 5.9, 1H, arom.), 7.94–7.92 (d, J = 8.9, 1H, arom.), 7.69–7.67 (d, J = 6.0, 1H, arom.), 7.57–7.55 (d, J = 8.8, 1H, arom.), 6.08 (s, 1H, CH-5), 3.57 (s, 3H, NCH3), 3.52 (s, 3H, NCH3); 13C-NMR (DMSO-d6): δ = 33.46 (CH), 45.9 (CH3), 125.08, 127.9, 128.2, 128.9, 129.52, 131.20, 161.9 (C=O), 169.8 (C=S) ppm; MS: m/z (%) = M+ + 2, 422 (0.3), M+, 420 (1), 129 (19), 74 (39), 69 (100); Anal. calcd. for C17H14ClN5O2S2 (419.90): C, 48.63; H, 3.63; N, 16.68. Found: C, 49.02; H, 2.86; N, 17.01.

1,9-Dimethyl-5-(3-nitrophenyl)-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d] pyrimidine-4,6(1H,7H)-dione (9b). Yield (method A): 86%; m.p. >300 °C; reflux 5 h; IR (n class="Chemical">KBr) νmax (cm−1): 3461 (NH), 3060 (CH arom.), 2856 (CH aliph.), 1729 (C=O), 1582 (C=N), 1166, 1092 (C=S); 1H-NMR (DMSO-d6): 12.56 (s, 1H, NH), 12.05 (s, 1H, NH), 8.15 (s, 1H, NH(10)), 8.06 (s, 1H, arom.), 7.96–7.48 (m, 3H, arom.), 6.22 (s, 1H, CH-5), 3.58 (s, 3H, NCH3), 3.52 (s, 3H, NCH3); 13C-NMR (DMSO-d6): δ = 33.56 (CH), 46.33 (CH3), 125.24, 126.72, 127.45, 128.12, 128.43, 129.21, 129.91, 131.82, 162.4 (C=O), 171.3 (C=S) ppm; MS: m/z (%) = M+, 430 (5), 428 (16), 299 (18), 106 (100); Anal. calcd. for C17H14N6O4S2 (430.46): C, 47.43; H, 3.28; N, 19.52. Found: C, 47.94; H, 2.85; N, 19.97.

1,9-Dimethyl-5-(4-nitrophenyl)-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d] pyrimidine-4,6(1H,7H)-dione (9c). Yield (method A): 83%; m.p. >300 °C; reflux 4 h, IR (n class="Chemical">KBr) νmax (cm−1): 3384 (NH), 3034 (CH arom.), 2918 (CH aliph.), 1705 (C=O), 1520 (C=N), 1134, 1086 (C=S); 1H-NMR (DMSO-d6): 11.93 (s, 2H, 2NH), 8.46 (s, 1H, NH(10)), 8.06–8.04 (s, J = 7.5, 2H, arom.), 7.29–7.27 (s, J = 7.5, 2H, arom.), 6.20 (s, 1H, CH-5), 3.51 (s, 6H, 2 NCH3); 13C-NMR (DMSO-d6): δ = 33.55 (CH), 46.41 (CH3), 125.27, 128.11, 128.43, 128.93, 129.86, 131.34, 161.93 (C=O), 169.78 (C=S) ppm; MS: m/z (%) = M+, 430 (1), 332 (24), 106 (68), 91 (14), 78 (100); Anal. calcd. for C17H14N6O4S2 (430.46): C, 47.43; H, 3.28; N, 19.52. Found: C, 48.01; H, 2.86; N, 19.93.

5-(4-Bromophenyl)-1,9-dimethyl-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d] pyrimidine-4,6(1H,7H)-dione (9d). Yield (method A): 90%; m.p. >300 °C; reflux 4 h; IR (KBr) νmax (cm−1): 3220 (NH), 3046 (CH arom.), 2818 (CH aliph.), 1721 (C=O), 1567 (C=N), 1107, 1068 (C=S); 1H-NMR (DMSO-d6): 12.61 (s, 1H, NH), 12.52 (s, 1H, NH), 8.28–8.26 (d, 1H, arom.), 8.05–8.03 (d, J = 8.6, 1H, arom.), 7.99–7.97 (d, J = 8.8, 2H, arom.), 7.84 (s, 1H, NH(10)), 6.06 (s, 1H, CH-5), 3.56 (s, 3H, NCH3), 3.51 (s, 3H, NCH3); 13C-NMR (DMSO-d6): δ = 33.48 (CH), 45.88 (CH3), 125.16, 127.89, 128.16, 128.91, 129.47, 131.16, 161.89 (C=O), 169.77 (C=S) ppm; MS: m/z (%) = M+ + 2, 466 (2), M+, 464 (6), 200 (58), 95 (100); Anal. calcd. for C17H14BrN5O2S2 (464.35): C, 43.97; H, 3.04; N, 15.08 Found: C, 44.34; H, 2.60; N, 15.31.

5-(2-Hydroxyphenyl)-1,9-dimethyl-2,8-dithioxo-2,3,5,8,9,10-hexahydropyrimido [5',4':5,6]pyrido[2,3-d]pyrimidine-4,6(1H,7H)-dione (9e). Yield (method A): 81%; m.p. >300 °C; reflux 6 h; IR (KBr) νmax (cm−1): 3321 (NH), 3096 (CH arom.), 2901 (CH aliph.), 1684 (C=O), 1580 (C=N), 1141, 1081 (C=S); 1H-NMR (DMSO-d6): 12.44 (s, 1H, OH), 12.36 (s, 1H, NH), 10.96 (s, 1H, NH), 8.40–8.38 (d, 1H, arom.), 8.36–8.34 (d, 1H, arom.), 8.28–8.26 (d, 1H, arom.), 7.88 (s, 1H, NH(10)), 6.91–6.89 (d, 1H, arom.), 6.17 (s, 1H, CH-5), 3.56 (s, 6H, 2 NCH3); 13C-NMR (DMSO-d6): δ = 33.46 (CH), 45.64 (CH3), 125.02, 127.84, 128.12, 128.76, 129.32, 131.14, 161.85 (C=O), 169.73 (C=S) ppm; MS: m/z (%) = M+, 401 (0.4), 109 (36), 106 (100), 78 (51), 43 (52); Anal. calcd. for C17H15N5O3S2 (401.46): C, 50.86; H, 3.77; N, 17.44. Found: C, 51.27; H, 3.31; N, 17.70.

4. Antimicrobial Activity

4.1. Microorganisms and Culture Media

Staphylococcus aureus (Gram-positive), n class="Species">Escherichia coli (Gram-negative) and Candida albicans (yeast) were obtained from the microbiology lab of the Faculty of Medicine, Jazan University Culture Collection. All bacteria strains were maintained and kept at −80 °C until used. Müller–Hinton agar (MHA) and Sabouraud dextrose agar (SDA) were obtained from the microbiology lab of the Faculty of Medicine, Jazan University.

4.2. Disc Diffusion Method

The disc diffusion method for antimicrobial susceptibility testing was carried out according to the standn class="Chemical">ard method [26] to assess the presence of antibacterial activities of the tested chemical substances. A microbial culture (which has been adjusted to 0.5 McFarland standards) was used to inoculate Müller–Hinton agar and Sabouraud dextrose agar plates evenly using a sterile swab. The plates were dried for 15 min and then used for the sensitivity test. The discs that had been impregnated with 1 mg/mL of the chemical samples were placed on the Müller–Hinton agar and Sabouraud dextrose agar surface. Each test plate comprises six discs: one negative control (disc with the used solvent) and five treated discs. The negative control was DMSO (100%). Besides the controls, each plate had five treated discs were placed about equidistant from each other. The plate was then incubated at 37 °C for 18–24 h depending on the species of bacteria or yeast used in the test. After the incubation, the plates were examined for the inhibition zone. The inhibition zone was then measured using calipers and recorded. The test was performed in triplicates to ensure reliability.

4.3. Minimum Inhibition Concentration Determination

Minimum inhibition concentration determination was performed according to the method described in [27,28,29]. Serial dilutions of the chemical substances that showed antimicrobial activity with the disc diffusion method (a reasonable inhibition zone) (a range of 10 dilutions from 0.1 µg/mL up to 1 µg/mL) are added to a Müller–Hinton or and n class="Chemical">Sabouraud dextrose broth medium in separate test tubes. These tubes are then inoculated with the microorganism that one wishes to test (Staphylococcus aureus, Escherichia coli or Candida albicans). The tubes are allowed to incubate overnight. Broth tubes that appear turbid are indicative of bacterial growth, while tubes that remain clear indicate no growth. The MIC of the antibiotic is the lowest concentration that does not show growth.

5. Conclusions

Simple methylation methods were used for the methylation of S-H and N-H in the 2-thioxanthines. Also, the formation of tricyclic dipyrimidopyridines was developed. Compounds 7d and 9a showed a significant effect against Staphylococcus aureus and Candida albicans.